Glenview Trust Co acquired a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 1,267 shares of the company’s stock, valued at approximately $494,000.
Several other hedge funds have also recently modified their holdings of the business. Palisade Asset Management LLC purchased a new stake in shares of HCA Healthcare during the third quarter valued at $26,000. MidFirst Bank bought a new position in HCA Healthcare during the second quarter valued at approximately $28,000. Clearstead Trust LLC purchased a new stake in HCA Healthcare during the 2nd quarter valued at $29,000. Cedar Mountain Advisors LLC bought a new stake in shares of HCA Healthcare in the first quarter worth $33,000. Finally, JPL Wealth Management LLC bought a new position in shares of HCA Healthcare in the 3rd quarter worth approximately $33,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.
Analysts Set New Price Targets
A number of research analysts have recently weighed in on HCA shares. Deutsche Bank Aktiengesellschaft set a $476.00 price objective on HCA Healthcare in a research report on Monday, July 27th. Royal Bank Of Canada reiterated an “outperform” rating and issued a $435.00 price target on shares of HCA Healthcare in a research report on Monday, July 27th. The Goldman Sachs Group lowered their target price on shares of HCA Healthcare from $558.00 to $485.00 and set a “buy” rating on the stock in a research note on Tuesday, July 28th. Wells Fargo & Company raised their price target on HCA Healthcare from $369.00 to $381.00 and gave the company an “equal weight” rating in a report on Monday, August 3rd. Finally, Morgan Stanley lowered their price target on HCA Healthcare from $425.00 to $380.00 and set an “underweight” rating on the stock in a report on Monday, July 27th. Fourteen equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, HCA Healthcare has a consensus rating of “Moderate Buy” and a consensus target price of $462.64.
HCA Healthcare Stock Performance
NYSE HCA opened at $417.57 on Friday. The company has a market capitalization of $90.40 billion, a P/E ratio of 13.98, a P/E/G ratio of 1.45 and a beta of 1.10. The stock has a 50 day moving average price of $401.08 and a 200-day moving average price of $441.46. HCA Healthcare, Inc. has a one year low of $353.99 and a one year high of $556.52.
HCA Healthcare (NYSE:HCA – Get Free Report) last issued its quarterly earnings data on Friday, July 24th. The company reported $7.59 EPS for the quarter, topping analysts’ consensus estimates of $7.56 by $0.03. The business had revenue of $20.23 billion during the quarter, compared to analysts’ expectations of $19.76 billion. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The business’s revenue was up 8.7% on a year-over-year basis. During the same period last year, the company posted $6.84 EPS. As a group, equities analysts predict that HCA Healthcare, Inc. will post 29.42 EPS for the current fiscal year.
HCA Healthcare Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be given a dividend of $0.78 per share. The ex-dividend date is Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.7%. HCA Healthcare’s payout ratio is 10.45%.
HCA Healthcare Profile
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Read More
- Five stocks we like better than HCA Healthcare
- From SaaS-pocalypse to Perfect Storm: Workday’s AI Growth Story Strengthens
- These 3 GARP Stocks Show Why Growth and Value Do Not Have to Clash
- Venture Into High-Volatility Corners of the Market With These 3 ETFs
- 3 Retail Stocks to Watch After a Big Consumer Earnings Week
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
